Poor Outcomes Among Patients Aged 65 and Older Presenting to the Emergency Department(EDEN-RICAPPS Study)
Launched by HOSPITAL GALDAKAO-USANSOLO · Sep 25, 2025
Trial Information
Current as of October 20, 2025
Completed
Keywords
ClinConnect Summary
HYPOTHESIS
Current emergency triage systems (MAT, SET, others), as well as early warning systems (NEWS-2), are unable to detect all geriatric patients at risk of poor outcomes, partly due to:
1. the reference values for vital signs are not the same as in the population under 65 years of age
2. atypical presentations of diseases occur more frequently than in the population under 65 years of age.
3.- It is possible to develop and validate predictive models of poor outcomes in the emergency department (death in the emergency department, admission to the ICU or conventional admission, as wel...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients over 65 years of age who attend the emergency department for any reason during the study period
- Exclusion Criteria:
- • arrival at the emergency department in critical condition in pre-mortem situations,
- • absence of a carer in situations of severe dependency
- • presence of mental illness, and refusal to participate in the study.
About Hospital Galdakao Usansolo
Hospital Galdakao-Usansolo is a leading healthcare institution in the Basque Country, Spain, dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence, the hospital integrates cutting-edge technology and a multidisciplinary approach to support a diverse range of clinical studies. Its experienced team of healthcare professionals and researchers collaborates closely with patients, ensuring rigorous adherence to ethical standards and regulatory requirements. By fostering a culture of research and collaboration, Hospital Galdakao-Usansolo aims to contribute significantly to the advancement of medical knowledge and the development of new therapeutic options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Usansolo, Bizkaia, Spain
Patients applied
Trial Officials
Susana García Gutiérrez
Principal Investigator
Osakidetza, Hospital Galdakao-Usansolo
Juan Gonzalez del Castillo, PhD
Study Director
Hospital San Carlos, Madrid
Oscar Miró, PhD
Study Chair
Hospital Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported